je.st
news
Tag: collaboration
CPP Expo NYC 2016 to focus on collaboration and business development
2015-10-21 07:00:00| Label and Narrow Web Breaking News
Scheduled for June 14-16, 2016, in New York, NY, USA, the event will focus on packaging materials production.
Tags: business
development
focus
collaboration
Germany's Bayer eyes Boston area for biotech collaboration
2015-10-20 06:05:35| Biotech - Topix.net
Bayer AG, one of the last big European pharmaceutical companies without a presence in the Boston area, may soon be setting up a local outpost to work with biotech startups and academic researchers on drug discovery. Bayer CEO Marijn Dekkers said in an interview Monday that the German company is in "advanced stages of discussion" about opening a site here modeled on its collaboration offices in San Francisco, Toyko, and Shanghai, which each employ up to 100 people.
Tags: area
eyes
boston
collaboration
Germany's Bayer eyes Boston area for biotech collaboration
2015-10-20 00:48:46| Chemicals - Topix.net
Bayer AG, one of the last big European pharmaceutical companies without a presence in the Boston area, may soon be setting up a local outpost to work with biotech startups and academic researchers on drug discovery. Bayer CEO Marijn Dekkers said in an interview Monday that the German company is in "advanced stages of discussion" about opening a site here modeled on its collaboration offices in San Francisco, Toyko, and Shanghai, which each employ up to 100 people.
Tags: area
eyes
boston
collaboration
Lilly And ImaginAb Announce Preclinical Immuno-Oncology Collaboration
2015-10-14 06:26:33| drugdiscoveryonline News Articles
Eli Lilly and Company (NYSE: LLY) and ImaginAb Inc. are pleased to announce a preclinical research collaboration to study potential novel T-cell-based immuno-oncology therapies.
Tags: collaboration
announce
lilly
preclinical
Incyte and Merck Expand Clinical Collaboration to Include Phase 3 Study Investigating the Combination of Epacadostat with Keytruda (pembrolizumab) as First-line Treatment for Advanced Melanoma
2015-10-13 13:30:03| Merck.com - Product News
Dateline City: WILMINGTON, Del. and KENILWORTH, N.J. Pivotal study to evaluate Incytes IDO1 inhibitor in combination with Mercks anti-PD-1 therapy in patients with advanced or metastatic melanoma WILMINGTON, Del. and KENILWORTH, N.J. -- Incyte Corporation (Nasdaq: INCY) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the expansion of the companies ongoing clinical collaboration to include a Phase 3 study evaluating the combination of epacadostat, Incytes investigational selective IDO1 inhibitor, with Keytruda (pembrolizumab), Mercks anti-PD-1 therapy, as first-line treatment for patients with advanced or metastatic melanoma. Language: English read more
Tags: for
advanced
include
study
Sites : [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] next »